Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer

This trial was designed to assess efficacy and safety of erlotinib with sorafenib in the treatment of patients with advanced pancreatic adenocarcinoma. An exploratory correlative study analyzing pretreatment serum samples using a multivariate protein mass spectrometry-based test (VeriStrat®), previo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cardin, Dana B, Goff, Laura, Li, Chung-I, Shyr, Yu, Winkler, Charles, DeVore, Russell, Schlabach, Larry, Holloway, Melanie, McClanahan, Pam, Meyer, Krista, Grigorieva, Julia, Berlin, Jordan, Chan, Emily
Formato: Artigo
Lenguaje:Inglês
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4101748/
https://ncbi.nlm.nih.gov/pubmed/24574334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.208
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares